Mild Cognitive Impairment Epidemiology and Risk Factors

Mild cognitive impairment (MCI) occupies the boundary between normal cognitive ageing and dementia, manifesting as measurable decline in memory, attention or executive function that does not yet significantly disrupt daily life. Globally, prevalence estimates vary from around 5% to over 30% among older adults, with higher rates reported in institutional settings and in populations screened using sensitive instruments. Key influences on MCI prevalence include advancing age, female sex, low educational attainment, vascular comorbidities and markers of systemic inflammation. Incidence studies suggest that up to one-quarter of individuals with MCI convert to dementia within three to five years, although rates vary by diagnostic criteria and underlying aetiology. Emerging evidence points to neuroinflammatory processes, metabolic dysregulation and lifestyle factors—such as physical inactivity and low social engagement—as modifiable risk elements. Heterogeneity in case definitions and assessment tools complicates direct comparisons across regions, but harmonised criteria and standardised screening are improving understanding of the global burden. Early identification of MCI affords opportunity for targeted risk reduction, resource planning and the development of interventions aimed at delaying progression to dementia.

Research from Nature Portfolio

A large household survey of adults aged 30 to 65 years in urban Thailand found that one in three participants met criteria for MCI, with nearly half reporting neuropsychiatric symptoms such as sleep disturbance, anxiety and irritability. The study revealed a clear age-related increase in prevalence even below retirement age and highlighted the potential benefit of extending cognitive screening to mid-life cohorts. It also underlined the association between neuropsychiatric burden and early cognitive decline, suggesting that interventions in younger adults could attenuate progression later in life.

Mild Cognitive Impairment Epidemiology and Risk Factors publication trend

The graph below shows the total number of articles in mild cognitive impairment epidemiology and risk factors across all publications each year (not limited to Nature Index journals).

Technical terms

Mild Cognitive Impairment (MCI): A clinical syndrome of noticeable cognitive decline greater than expected for age and education, without significant impairment in daily activities.

Prevalence: The proportion of a population affected by a condition at a specific point in time.

Incidence: The rate at which new cases of a condition occur in a population over a defined period.

Meta-analysis: A statistical method that combines results from multiple studies to derive a pooled estimate.

Cross-sectional study: An observational design in which data are collected at a single point in time from a defined population.

Neutrophil-to-lymphocyte ratio (NLR): A blood‐derived marker of systemic inflammation calculated by dividing the absolute neutrophil count by the absolute lymphocyte count.

References

1. A household survey of the prevalence of subjective cognitive decline and mild cognitive impairment among urban community-dwelling adults aged 30 to 65. Scientific Reports (2024).
2. Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys. Translational Psychiatry (2023).
3. The neutrophil-to-lymphocyte ratio is associated with mild cognitive impairment in community-dwelling older women aged over 70 years: a population-based cross-sectional study. Frontiers in Aging Neuroscience (2023).
4. Risk of conversion from mild cognitive impairment to dementia in low‐ and middle‐income countries: A systematic review and meta‐analysis. Alzheimer's & Dementia: Translational Research & Clinical Interventions (2022).